0.00
—
Close of 30 Oct 2026, in USD
About RBC Life Sciences
Its shares trade under the ticker RBCL. It has been listed since 27 March 1996. In the fiscal year to 31 December 2016, it reported revenue of $25.8m and a net loss of $756,284. At that date it held total assets of $11.0m and shareholders' equity of $7.1m.
RBC Life Sciences, Inc. engages in the marketing and distribution of nutritional supplements and personal care products. The company is headquartered in Irving, Texas. The firm's segments include Nutritional Products and Medical Products. Its Nutritional Products segment distributes products in over three categories: wellness products, fitness products and personal care products. Its Medical Products segment distributes wound care products. Nutritional Products are marketed under the RBC Life brand name. As of September 30, 2015, its Nutritional Products segment manufactured and distributed a line of over 100 nutritional supplements and personal care products, including herbs, vitamins and minerals, as well as natural skin, hair and body care products. As of September 30, 2015, it marketed a line of over 35 wound care products under the MPM Medical brand name through a subsidiary operating primarily in the United States.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Personal Products
- Listed since
- 27 Mar 1996
- Employees
- 76
- Website
- rbclifesciences.com ↗
Leadership
Pay as last reported
- Clinton HowardChairman of the Board, since 1991$313,184
- Steven BrownPresident, Chief Executive Officer, Director, since 1994$295,637
- Douglas WheelerVice President - Operations$138,840
- Barton DangerfieldVice President - Marketing
- Daley SeekerChief Financial Officer, Vice President - Finance, Treasurer, Secretary
- Mr. Andrew HowardDirector, since 1997$226,993
- Joseph PhilippIndependent Director
- Ms. Cynthia TysingerIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- RBC Life Sciences Inc has a strong reputation in the pharmaceutical industry and is recognized for its high-quality products.
- The company has a wide range of products and a diverse portfolio, allowing it to cater to various customer needs.
- RBC Life Sciences Inc has a robust research and development (R&D) department, which enables it to stay innovative and develop new products and solutions.
- The company has a strong global presence, with a well-established distribution network in multiple countries.
Weaknesses
- RBC Life Sciences Inc may face challenges in terms of regulatory compliance, as the pharmaceutical industry is heavily regulated.
- The company may have limited resources compared to larger competitors, which could affect its ability to invest in marketing and expansion efforts.
- RBC Life Sciences Inc relies on third-party suppliers for some of its raw materials, which could result in potential supply chain disruptions.
Opportunities
- The growing demand for organic and natural products presents an opportunity for RBC Life Sciences Inc to expand its product offering and capture a larger market share.
- RBC Life Sciences Inc can capitalize on emerging markets, such as Asia and Latin America, where there is a rising middle class with increased disposable income and health consciousness.
- Advancements in technology and digitalization provide opportunities for RBC Life Sciences Inc to enhance its manufacturing processes and improve operational efficiency.
Threats
- Intense competition in the pharmaceutical industry poses a threat to RBC Life Sciences Inc's market position and profitability.
- Changing government regulations and policies may impact the pricing and availability of pharmaceutical products, creating uncertainty for the company.
- The potential for counterfeit products and intellectual property infringement poses a threat to RBC Life Sciences Inc's brand reputation and revenue.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.